The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases.
Washington D.C. [USA], Nov. 13 (ANI): A new study has found that tumor necrosis factor (TNF) inhibitors, a group of biologic drugs used to treat children with juvenile idiopathic arthritis, is not linked to a possible increased risk of cancer.
Washington D.C, Aug 1 (ANI): What if there was a device that could act a bit like a "pharmacy on demand" by creating a variety of drugs? Turns out, a team of researchers has already turned this idea into a reality.